Posted: 01 Jun 2016 09:06 AM PDT
In recent years, the level of scrutiny on foreign pharmaceutical manufacturing facilities in countries like China and India has skyrocketed—along with the demand and dependence of western countries on the supply of goods coming from those facilities. With the international pharmaceutical supply chain imperiled like never before, what can drug manufacturers do to protect themselves?
This free webinar, presented by Dechert LLP and Hyman, Phelps & McNamara P.C., will discuss recent pharmaceutical supply chain developments and what steps companies need to take to prevent and remediate compliance issues in the context of:
Wednesday, June 22, 2016 12:00 p.m. - 1:00 p.m. ET Where This presentation will be simulcast via Webex as a webinar. Please click here to register. Speakers Douglas B. Farquhar Director Hyman, Phelps & McNamara PC Washington, D.C. Mark I. Schwartz Of Counsel Hyman, Phelps & McNamara PC Washington, D.C. Jeremy B. Zucker Partner Dechert LLP Washington, D.C. Lewis Ho Partner Dechert LLP Hong Kong Kareena Teh Partner Dechert LLP Hong Kong Application for accreditation of this program for Continuing Legal Education (CLE) in California, Massachusetts, New Jersey, and New York is currently pending. For questions, please contact Reiko Tate (reiko.tate@dechert.com). |
viernes, 3 de junio de 2016
FDA Law Blog: International Pharmaceutical Supply Chain Imperiled Like Never Before: A Webinar Presented by Dechert LLP and Hyman, Phelps & McNamara PC
FDA Law Blog: International Pharmaceutical Supply Chain Imperiled Like Never Before: A Webinar Presented by Dechert LLP and Hyman, Phelps & McNamara PC
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario